missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Pinatuzumab Recombinant Monoclonal Antibody
GREENER_CHOICE

Product Code. 30284030
Change view
Click to view available options
Menge:
1 mg
100 μg
Unit Size:
1 Milligramm
100 Mikrogramm
Product Code. Menge unitSize
30284030 100 μg 100 Mikrogramm
30282740 1 mg 1 Milligramm
2 options
This item is not returnable. View return policy

Product Code. 30284030

Brand: Invitrogen™ MA559781

Bitte Sie sich an, um diesen Artikel zu kaufen. Sie benötigen ein Web-Konto? Registrieren Sie sich noch heute!

This item is not returnable. View return policy

Recombinant Monoclonal Antibody

For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.

pinatuzumab vedotin is under investigation in clinical trial NCT01691898, A Study of pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL).
TRUSTED_SUSTAINABILITY

Specifications

Antigen Pinatuzumab Humanized
Anwendungen ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance
Klassifikation Recombinant Monoclonal
Konzentration 1 mg/mL
Konjugat Unconjugated
Zusammensetzung 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2
Gen-Alias ACD22-VCMMAE; DCDT2980S; FCU2803; RG-7593; RO5541072-000
Wirtsspezies Human
Reinigungsverfahren Protein A
Menge 100 μg
Regulatorischer Status RUO
Primär oder sekundär Primary
Zielspezies Human
Inhalt und Lagerung -20°C, Avoid Freeze/Thaw Cycles
Produkttyp Antibody
Form Lyophilized
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.